
Background Vitamin B12 deficiency is a clinically important complication of long-term metformin therapy and may contribute to hematological and neurological complications in patients with type 2 diabetes mellitus. Although metformin is widely used in Africa, comprehensive evidence on the prevalence and associated factors of vitamin B12 deficiency among metformin-treated patients remains limited and fragmented. This systematic review and meta-analysis aimed to estimate the pooled prevalence of vitamin B12 deficiency and identify factors associated with its occurrence among adults with type 2 diabetes mellitus receiving metformin in Africa. Methods Following PRISMA 2020 guidelines, we searched PubMed, Cochrane Library, AJOL, AIM, DOAJ, ScienceDirect, Google Scholar, and reference lists from January 1, 2000, to October 18, 2026. Eligible studies reported the prevalence of vitamin B12 deficiency in metformin-treated adults with type 2 diabetes mellitus. Methodological quality was assessed using JBI tools, and pooled prevalence was estimated using a random-effects REML model in Stata 17.0. Results Nineteen studies involving 3108 adults with type 2 diabetes mellitus from 10 African countries were included. The pooled prevalence of vitamin B12 deficiency was 14.7% (95% CI: 9.7–21.6%), with substantial between-study heterogeneity (I2 = 94.69%) and a 95% prediction interval of 2.0–59.7%, indicating considerable variation in the expected prevalence across different clinical and population settings. The included studies used heterogeneous study-defined diagnostic criteria and laboratory methods for vitamin B12 deficiency. Therefore, the pooled estimate should be interpreted as a summary of the available African studies rather than as a continent-wide prevalence estimate. Narrative synthesis suggested that older age, longer metformin exposure, and higher metformin doses were the most consistently reported factors associated with vitamin B12 deficiency. Conclusion The available African studies yielded a pooled prevalence of approximately 14.7%, based on study-specific definitions of vitamin B12 deficiency. Vitamin B12 assessment may be particularly relevant in patients receiving long-term or high-dose metformin, especially when neurological or hematological manifestations are present. Systematic review registrations PROSPERO (CRD420261463974).
Obesity induces catecholamine resistance in adipose tissue, which impairs lipolysis and reduces energy expenditure. Here, we show that phillyrin attenuates catecholamine resistance in obese adipose tissue in association with suppression of the IL-6R–STAT3–ERK1/2 positive feedback loop. In high-fat diet (HFD)-induced obese mice, low-dose phillyrin (1 mg/kg) significantly elevated 24-h energy expenditure and oxygen consumption. It also markedly enhanced β3-adrenergic-stimulated lipolysis in both visceral and subcutaneous adipose depots, accompanied by increased phosphorylation of hormone-sensitive lipase (HSL) at Ser660. Furthermore, phillyrin effectively rescued IL-6-induced catecholamine resistance both in vitro and in vivo. Mechanistically, phillyrin downregulated IL-6Rα expression and suppressed the phosphorylation of STAT3 (Tyr705) and ERK1/2, consistent with attenuation of the self-amplifying inflammatory loop that desensitizes β-adrenergic signaling. These findings implicate the IL-6R–STAT3–ERK1/2 positive feedback loop as a mediator of obesity-associated catecholamine resistance and support phillyrin as a promising therapeutic candidate for improving lipolytic capacity and metabolic homeostasis in obesity.
Objective This study aimed to simultaneously evaluate the relationship between body composition assessed by dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance analysis (BIA) with muscle strength in the same cohort of community-dwelling adults, and to compare the associations of these two modalities for handgrip and lower limb muscle strength. Methods A total of 94 community-dwelling adults (59 women, 35 men) aged ≥40 years underwent body composition assessment using DXA and BIA, along with isokinetic knee strength and handgrip strength measurements. Correlation and multiple linear regression analyses were performed to examine associations between body composition parameters and muscle strength, stratified by sex where appropriate. Results In the fully adjusted models (age, BMI, and sex), BIA-derived parameters remained significantly associated with handgrip strength (e.g., UEFFM: β = 0.646, p < 0.001; FFM: β = 0.428, p < 0.05), whereas most DXA-derived parameters were no longer significant. For knee extensor strength, DXA-derived appendicular and leg-specific lean mass indices remained significant (ALM: β = 0.579, p < 0.01; LELM: β = 0.510, p < 0.01), while among BIA parameters only FFM remained significant (β = 0.542, p < 0.05). For knee flexor strength, both DXA- and BIA-derived parameters showed significant associations (e.g., DXA ALM: β = 0.551, p < 0.01; BIA FFM: β = 0.650, p < 0.01). Segment-specific analyses revealed that lower limb strength correlated more strongly with leg-specific lean mass, while handgrip strength showed closer associations with arm-specific measures. Conclusion After adjustment for age, BMI, and sex, BIA and DXA showed modality-specific associations with muscle strength. BIA was more strongly associated with handgrip strength, whereas DXA-derived height-adjusted indices were more strongly associated with lower limb strength. These findings support the tailored use of BIA and DXA in functional assessment, although neither method directly measures skeletal muscle mass.
Disruptions in ketone metabolism can markedly impair energy homeostasis and clinical outcomes in individuals with certain inborn errors of metabolism (IEMs), making ketone monitoring an important component of disease management. Evidence for ketone monitoring has largely emerged from diabetes care, where it reduces the risk of diabetic ketoacidosis (DKA), hospitalizations, and healthcare costs. However, conventional ketone self-monitoring methods are limited by impracticality and lack of longitudinal data. Continuous ketone monitoring (CKM), which measures subcutaneous beta-hydroxybutyrate (BHB), overcomes these limitations by enabling real-time assessment of ketone dynamics. In this narrative review, we discuss emerging CKM technologies for the first time and outline their potential clinical utility in IEMs. However, direct clinical evidence supporting the use of CKM in IEMs is currently lacking, and further studies are needed to validate these proposed applications. In theory, CKM could improve metabolic control, seizure management, and prevent complications in disorders of ketolysis and in individuals with IEMs on ketogenic dietary therapies; help in early detection of catabolic states and metabolic decompensation; and enhance surveillance for DKA in IEM-associated insulin-deficient diabetes. Given the predictable metabolic vulnerability of patients with IEMs and the need for timely intervention, these disorders may represent a clinically meaningful early application of CKM beyond diabetes.
Unlike mammals, birds lack canonical brown adipose tissue and the UCP1 gene, yet exhibit UCP1-independent non-shivering thermogenesis (NST). In vitro, embryonic chicken mesenchymal cells differentiate into avian brown adipocyte-like cells (ABALCs) with multilocular lipid droplets, elevated mitochondrial density, and upregulated PGC-1α and PPARγ, activating a transfected mouse UCP1 promoter despite endogenous UCP1 loss. In vivo, gradual cold acclimatization or triiodothyronine (T3) induces beige-like adipocytes enriched in mitochondria within the subcutaneous neck depot (“neck warmer”), with increased avian uncoupling protein (avUCP), CIDEA, TBX1, and mitochondrial markers, while abdominal fat remains largely unresponsive. Skeletal muscle is the main site of NST, where SERCA/RyR-mediated calcium cycling and avUCP/ANT-associated mitochondrial uncoupling are candidate mechanisms; because avUCP is multifunctional (heat, redox and fuel handling), its expression is not by itself a read-out of heat output. Nutritional and microbial interventions—including polyunsaturated fatty acids, capsaicin, succinate, bile acids, and probiotics—have been associated with altered lipid metabolism and reduced visceral adiposity, although direct links to quantifiable heat production remain unestablished and non-thermogenic mechanisms (lipid digestion, hepatic lipogenesis, feed intake, inflammation) have not been excluded. Collectively, the evidence is consistent with, but does not yet prove, a conserved, multi-organ thermogenic metabolic network (TMN) in birds in which skeletal muscle predominates. Exploiting this latent capacity offers a conceptual framework for nutritional and management strategies to mitigate excessive fat deposition and enhance thermal resilience in commercial broilers, although the energetic trade-offs with growth and feed efficiency remain to be resolved. A structured roadmap integrating nutritional, microbial, environmental, and genetic approaches is proposed to test, and if validated to harness, the TMN for sustainable production.